This content is from: Portfolio J.C. Penney Poison Pill Thwarts Ackman, For Now J.C. Penney reaches into its bag of tricks and pulls out a poison pill to thwart Pershing Square’s Bill Ackman from taking over the company or taking a much bigger stake. By Stephen Taub October 18, 2010
This content is from: Premium When Poison Pills Aren’t Poisonous Companies are increasingly adopting poison pills to ward off activist investors. And sometimes, they’re just what the doctor ordered. By Stephen Taub August 23, 2013
This content is from: Premium Hedge Fund Targets Try New Flavor of Poison Pill So-called specific-purpose pills are gaining popularity among companies that are finding themselves on the business end of hedge fund activist campaigns. December 04, 2012
This content is from: Premium Icahn Inspires Another Poison Pill Hologic made the move after the legendary investor took a big stake. Is the pill just what the doctor ordered, or will it be bad medicine for investors? By Stephen Taub November 22, 2013
This content is from: Portfolio Activist Campaigns Fall, but Poison Pill Adoption Surges Shareholder activists launched fewer campaigns in the first quarter than they have in some time, but companies are bracing themselves for that to change. By Amanda Cantrell April 29, 2020
This content is from: Premium Daniel Loeb’s Sotheby’s Suit Targets New Takeover Defense Ploy The activist hedge fund manager’s suit against the auction house concerns a new variety of poison pill that target companies have been issuing of late. By Stephen Taub March 27, 2014
